Underweight: Trim 50% Now at $98-99, Move Stop to $103, De-risk Pre-Q3
Underweight rating maintained with disciplined execution: immediate ~50% trim at $98-99, residual stop moved to $103 (1x ATR above 200 SMA at $103.42), pre-earnings 15-20% de-risking tranche, and two-of-four re-engagement framework post-Q3. The aggressive analyst's full-Sell overreaches given the tier-1 Dividend Aristocrat floor ($99-101 basing pattern, 0.586 beta, $7.2B FCF, 54-year dividend streak), while full Hold exposes the position to gap risk through earnings. Underweight harvests exposure ahead of tier-2 risk ($94-97 lower Bollinger/May swing low) while preserving tier-1 carry. Price target of $97 reflects base-case breakdown risk if Q3 disappoints.
| Position | Action |
|---|---|
| At current levels ($98-99) | Trim ~50% of overweight allocation immediately |
| Week before Q3 2026 earnings print (mid-October) | De-risk additional 15-20% tranche, reducing residual from 50-55% to 35-40% of target weight |
| For tactical short overlay (1-2% portfolio notional, not at current levels) | Use $108.50 stop above the 50 SMA rejection zone |
Abbott's selloff represents capitulation on a diversified healthcare leader with a fortress balance sheet and multiple growth catalysts—not a structural breakdown requiring HOLD or SELL. The bear case misreads transient acquisition integration costs as business deterioration while ignoring oversold technicals and defensive macro appeal.
| Indicator | Value | Signal |
|---|---|---|
| Close | 98.83 | bearish |
| 10 EMA | 101.64 | bearish |
| 50 SMA | 106.98 | bearish |
| 200 SMA | 103.42 | bearish |
| RSI (14) | 29.91 | bearish |
| MACD | -1.95 | bearish |
| MACD Signal | -1.55 | bearish |
| MACD Histogram | -0.40 | bearish |
| Bollinger Lower Band | 97.64 | neutral |
| Bollinger Middle Band | 103.46 | bearish |
| ATR | 2.23 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MACD histogram establishing a higher low from current -0.40
Then: Qualified re-engagement signal (1 of 2 required)
Earnings compression is acquisition math, not operational decay — FCF remains robust at $7.2B
↩ rebuts: “Bear uses compressed earnings as bearish justification despite admitting it's 'acquisition-driven'”
· concedes: Bear acknowledges 'Defensive positioning appeal' and 'bond-substitute rotation' — contradicting his bearish conclusion; Bear admits earnings compression is 'acquisition-driven'; RSI collapsed from 77.97 (overbought) to 29.91 in 27 sessions — confirming oversold conditions exist; MACD did cross below signal on September 15 — confirming the down move occurred; Price is sitting on the lower Bollinger Band at $97.64 — technically at the band's 'doorstep' as bear notes
SELL/AVOID ABT with high conviction based on accelerating bearish momentum, deteriorating fundamentals, and hostile macro backdrop with no positive catalyst for at least two quarters.
· concedes: The bear thesis isn't perfect; Aging population tailwind is real but already priced in; Diversification works in a stable environment (but current environment is not stable)
→ vs conservative: The conservative analyst's 50% trim at stop 107 is effectively setting a stop above the breakdown level (R4 at 106.98), which is the exact resistance that just broke. This is not risk management but rather hope with a price tag, as they acknowledge franchise quality metrics (54 years dividend growth, beta 0.586, $7.2B FCF) while ignoring that the relative-value calculus has fundamentally shifted with Treasuries yielding double ABT's dividend.
→ vs neutral: The neutral 'hold and wait' position is the most dangerous as it requires absorbing full mark-to-market pain while waiting for basing that the technicals actively contradict. There is no basing pattern when price is below all moving averages with RSI at 29.9, no divergence, and MACD expanding negative. The 2.50% dividend yield is not a floor but rather a yield trap when Treasuries pay 5%+ risk-free, making the 'support' actually the mechanism of underperformance.
| neutral |
Support: 97.64 · 94 · 92 | Resistance: 101.65 · 103.42 · 103.46 · 106.98
ABT is in a confirmed downtrend with all technical indicators bearish. Price at $98.83 is below all moving averages (10 EMA: 101.64, 50 SMA: 106.98, 200 SMA: 103.42) with a death cross intact. RSI at 29.91 is oversold but showing no bullish divergence, and MACD at -1.95 crossed below signal on 2026-09-15 with expanding negative histogram indicating accelerating downside momentum. Bollinger lower band at 97.64 has been pierced with ATR contracting to 2.23. The final transaction proposal is HOLD/SELL with tactical bearish bias; any reversal requires RSI bullish divergence, MACD histogram contraction, and a close back above the 10 EMA.
Market Cap
$171.0B
Implied Share Price
$98–$107
52-Week Range
$81.97–$135.45
Beta
0.586
Shares Outstanding
~1.742B diluted
Dividend Yield
2.50%
TTM Revenue
$46.585B
TTM Net Income
$5.401B
TTM EPS
$3.09
TTM FCF
$7.21B
FCF/Share
~$4.14
FCF Conversion
133%
Q1 2025 Revenue
$10.358B
Q1 2025 Net Income
$1.325B
Q1 2025 Diluted EPS
$0.76
Q2 2025 Revenue
$11.142B
Q2 2025 Net Income
$1.779B
Q2 2025 Diluted EPS
$1.01
Q3 2025 Revenue
$11.342B
Q3 2025 Net Income
$1.644B
Q3 2025 Diluted EPS
$0.94
Q4 2025 Revenue
$11.369B
Q4 2025 Net Income
$1.776B
Q4 2025 Diluted EPS
$1.01
Q1 2026 Revenue
$11.459B
Q1 2026 Net Income
$1.077B
Q1 2026 Diluted EPS
$0.61
Q2 2026 Revenue
$11.164B
Q2 2026 Net Income
$1.077B
Q2 2026 Diluted EPS
$0.53
Q2 YoY Revenue Growth
+0.2%
Q2 YoY Net Income Change
-39.5%
Gross Margin
56.8%
Operating Margin
14.7%
Net Profit Margin
11.6%
R&D Spend
~$720M/qtr
SGA
~$3.1B/qtr
Q1 2026 Interest Expense
$174M
Q1 2025 Total Debt
$13.24B
Q1 2026 Total Debt
$34.05B
Q1 2026 LT Debt
$29.64B
Q1 2026 Net Debt
$27.24B
Q1 2025 Goodwill
$23.36B
Q1 2026 Goodwill
$35.22B
Q1 2026 Other Intangibles
$17.88B
Q1 2025 Total Assets
$81.45B
Q1 2026 Total Assets
$110.43B
Q1 2025 Stockholders Equity
$48.81B
Q1 2026 Stockholders Equity
$52.06B
Net Tangible Assets Q1 2025
+$19.19B
Net Tangible Assets Q1 2026
-$1.04B
Debt/Equity
63.2%
Interest Coverage
~10x
Current Ratio
1.38
Working Capital
$7.13B
Cash Equivalents
$6.80B
Accounts Receivable
$8.21B
Inventory
$6.99B
Q1 2025 Operating CF
$1.417B
Q1 2025 CapEx
-$484M
Q1 2025 FCF
$933M
Q1 2025 Dividends Paid
-$1.026B
Q2 2025 Operating CF
$2.047B
Q2 2025 CapEx
-$502M
Q2 2025 FCF
$1.545B
Q2 2025 Dividends Paid
-$1.029B
Q3 2025 Operating CF
$2.787B
Q3 2025 CapEx
-$496M
Q3 2025 FCF
$2.291B
Q3 2025 Dividends Paid
-$1.031B
Q4 2025 Operating CF
$3.315B
Q4 2025 CapEx
-$689M
Q4 2025 FCF
$2.626B
Q4 2025 Dividends Paid
-$1.030B
Q1 2026 Operating CF
$1.315B
Q1 2026 CapEx
-$399M
Q1 2026 FCF
$916M
Q1 2026 Dividends Paid
-$1.098B
Dividend Coverage
~1.7x
Share Repurchases
~$300M/qtr
PE TTM
31.98x
Forward PE
16.29x
PEG Ratio
1.85
PB Ratio
3.35x
PFCF
~23.7x
EV/EBITDA
~16x
Forward EPS
~$6.07
ROE
10.6%
ROA
5.3%
Q1 2026 Acquisition Size
~$19.8B
50-day MA
$107.00
200-day MA
$104.44
Strengths
Concerns
Abbott completed a ~$19.8B acquisition financed by $19.86B debt issuance in Q1 2026, driving total debt to $34.05B and Net Debt to $27.24B while turning tangible book value negative; near-term earnings have compressed significantly (Q2 2026 net income -39.5% YoY) due to elevated D&A, interest expense ($174M vs $131M), and integration costs. However, the underlying franchise remains solid with strong FCF of $7.21B TTM, 56.8% gross margins, and defensive characteristics (Beta 0.586), with consensus expecting EPS recovery to ~$6.07 that would justify current valuations at 16.3x forward P/E.
Macro: The week of September 30, 2026 was defined by a hawkish re-pricing of Fed expectations and a historic surge in long-dated Treasury yields, even as the equity market eked out weekly gains. The 30-year Treasury yields climbed to their highest level since 2002 — a generational long-end yield event — while mortgage rates hit 7.58%, approaching a 3-year high. Bond yields pushed higher as investors digested global risks and a higher-for-longer path for the Fed, with Moody's Mark Zandi warning that higher interest rates are already damaging the economy. The S&P 500 and Dow posted monthly losses in September, though indices notched weekly wins by Friday September 25 as oil eased and a cooler-than-expected inflation print briefly re-ignited tech. Prediction markets shifted dramatically: the Fed hold probability at the October 2026 meeting is 66% (+31.0pp week-over-week) while a +25bps hike probability rose to 34% (+31.0pp), with zero probability assigned to a cut. US recession odds remain low at 8% (+1.0pp), consistent with the soft-landing narrative, meaning yields are rising on term premium and fiscal concerns rather than recession risk.